Encephalopathies: the emerging diabetic complications

被引:147
作者
Sima, Anders A. F. [1 ,2 ]
机构
[1] Wayne State Univ, Dept Pathol, Detroit, MI 48201 USA
[2] Wayne State Univ, Dept Neurol, Detroit, MI 48201 USA
关键词
Type; 2; diabetes; Insulin resistance; Alzheimer's disease; 1; Insulin deficiency; Encephalopathy; HIPPOCAMPAL SYNAPTIC PLASTICITY; WHITE-MATTER HYPERINTENSITIES; FACTOR-KAPPA-B; ALZHEIMERS-DISEASE; C-PEPTIDE; COGNITIVE DYSFUNCTION; RISK-FACTORS; LIPID RAFTS; GLUCOSE-METABOLISM; INSULIN-RESISTANCE;
D O I
10.1007/s00592-010-0218-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic encephalopathies are now accepted complications of diabetes. They appear to differ in type 1 and type 2 diabetes as to underlying mechanisms and the nature of resulting cognitive deficits. The increased incidence of Alzheimer's disease in type 2 diabetes is associated with insulin resistance, hyperinsulinemia and hyperglycemia, and commonly accompanying attributes such as hypercholesterolemia, hypertension and obesity. The relevance of these disorders as to the emergence of dementia and Alzheimer's disease is discussed based on epidemiological studies. The pathobiology of accumulation of beta-amyloid and tau the hallmarks of Alzheimer's disease are discussed based on experimental data. Type 1 diabetic encephalopathy is likely to increase as a result of the global increase in the incidence of type 1 diabetes and its occurrence in increasingly younger patients. Alzheimer-like changes and dementia are not prominently increased in type 1 diabetes. Instead, the type 1 diabetic encephalopathy involves learning abilities, intelligence development and memory retrieval resulting in impaired school and professional performances. The major underlying component here appears to be insulin deficiency with downstream effects on the expression of neurotrophic factors, neurotransmitters, oxidative and apoptotic stressors resulting in defects in neuronal integrity, connectivity and loss commonly occurring in the still developing brain. Recent experimental data emphasize the role of impaired central insulin action and provide information as to potential therapies. Therefore, the underlying mechanisms resulting in diabetic encephalopathies are complex and appear to differ between the two types of diabetes. Major headway has been made in our understanding of their pathobiology; however, many questions remain to be clarified. In view of the increasing incidence of both type 1 and type 2 diabetes, intensified investigations are called for to expand our understanding of these complications and to find therapeutic means by which these disastrous consequences can be prevented and modified.
引用
收藏
页码:279 / 293
页数:15
相关论文
共 138 条
[1]   Insulin resistance and executive dysfunction in older persons [J].
Abbatecola, AM ;
Paolisso, G ;
Lamponi, M ;
Bandinelli, S ;
Lauretani, F ;
Launer, L ;
Ferrucci, L .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (10) :1713-1718
[2]   Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT) [J].
Akisaki, Taichi ;
Sakurai, Takashi ;
Takata, Toshihiro ;
Umegaki, Hiroyuki ;
Araki, Atsushi ;
Mizuno, Sachiko ;
Tanaka, Shiro ;
Ohashi, Yasuo ;
Iguchi, Akihisa ;
Yokono, Koichi ;
Ito, Hideki .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2006, 22 (05) :376-384
[3]   Diabetes mellitus and risk of developing Alzheimer disease - Results from the Framingham study [J].
Akomolafe, Abimbola ;
Beiser, Alexa ;
Meigs, Phdjames B. ;
Au, Rhoda ;
Green, Robert C. ;
Farrer, Lindsay A. ;
Wolf, Philip A. ;
Seshadri, Sudha .
ARCHIVES OF NEUROLOGY, 2006, 63 (11) :1551-1555
[4]  
[Anonymous], 2010, ALTERN MED REV, V15, P76
[5]  
[Anonymous], DIABETES RES CLIN PR
[6]   Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function [J].
Arvanitakis, Z ;
Wilson, RS ;
Bienias, JL ;
Evans, DA ;
Bennett, DA .
ARCHIVES OF NEUROLOGY, 2004, 61 (05) :661-666
[7]   Effects of repeated hypoglycemia on cognitive function - A psychometrically validated reanalysis of the Diabetes Control and Complications Trial Data [J].
Austin, EJ ;
Deary, IJ .
DIABETES CARE, 1999, 22 (08) :1273-1277
[8]   Cholinergic and glutamergic receptor functional regulation in long-term, low dose somatotropin and insulin treatment to ageing rats: Rejuvenation of brain function [J].
Balakrishnan, Savitha ;
Mathew, Jobin ;
Paulose, C. S. .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2010, 314 (01) :23-30
[9]  
Biessels GJ, 2007, CONTEMP DIABETES, P187, DOI 10.1007/978-1-59745-311-0_11
[10]   Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment [J].
Biessels, GJ ;
Kamal, A ;
Urban, IJA ;
Spruijt, BM ;
Erkelens, DW ;
Gispen, WH .
BRAIN RESEARCH, 1998, 800 (01) :125-135